Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Hydroxyprogesterone caproate, sold under the brand name Delalutin among others, is a medication used to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth. In March 2023, the manufacturer, Covis Pharma, agreed to withdraw the drug from the US market. The approval of this drug substance was…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Hydroxyprogesterone caproate.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Hydroxyprogesterone caproate shows recurring relationship patterns in the source. For example, Hydroxyprogesterone caproate → After, Along, Delalutin, Due, FDA, FDA Accelerated Approval Programs, February, It, Japan, Karl Junkmann, KV Pharmaceutical, Makena, NIH-sponsored, PROLONG, Renewed, Schering AG, Squibb, The, The FDA, Under Another extracted example is Hydroxyprogesterone caproate → Based, Drug Administration, FDA, Furthermore, Guidelines, Health, Hydroxyprogesterone, III, IM, In, Level, Maternal Fetal Medicine Clinic, May, National Institutes, NIH, Of, One, Society, The, There. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
caproate hydroxyprogesterone progesterone intramuscular women injection mg found used birth medication 17α-hydroxyprogesterone study also brand pregnant effects preterm activity name
TTTA extracted 167 structured relationships around Hydroxyprogesterone caproate. Examples in this analysis include Hydroxyprogesterone caproate → 3D model (JSmol) → Interactive image and Hydroxyprogesterone caproate → ATC code → G03DA03 (WHO) G03FA02 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Hydroxyprogesterone caproate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Hydroxyprogesterone caproate | ATC code | G03DA03 (WHO) G03FA02 (WHO) | 1.00 | infobox |
| Hydroxyprogesterone caproate | Bioavailability | Oral: Very low (~3% in rats) Intramuscular: 100% (in rats) | 1.00 | infobox |
| Hydroxyprogesterone caproate | CAS Number | 630-56-8 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChEBI | CHEBI:5812 | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChEMBL | ChEMBL1200848 | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChemSpider | 148552 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | CompTox Dashboard (EPA) | DTXSID6043915 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Drug class | Progestogen; Progestin; Progestogen ester; Antigonadotropin | 1.00 | infobox |
| Hydroxyprogesterone caproate | DrugBank | DB06789 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | ECHA InfoCard | 100.010.127 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Elimination half-life | Non-pregnant: 7.8 days Singlet: 16–17 days Twins: 10 days | 1.00 | infobox |
| Hydroxyprogesterone caproate | Excretion | Feces: 50% Urine: 30% | 1.00 | infobox |
| Hydroxyprogesterone caproate | Formula | C27H40O4 | 1.00 | infobox |
| Hydroxyprogesterone caproate | KEGG | D00949 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Legal status | US: withdrawn | 1.00 | infobox |
| Hydroxyprogesterone caproate | Metabolism | Reduction and hydroxylation (via CYP3A4, CYP3A5, CYP3A7) and conjugation (glucuronidation, sulfation, acetylation) | 1.00 | infobox |
| Hydroxyprogesterone caproate | Molar mass | 428.613 g·mol−1 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Other names | OHPC; Hydroxyprogesterone capronate; Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate; 17α-OHPC; 17-Hydroxyprogesterone caproate; 17-OHPC; 17-HPC; 17α-HPC; HPC; L… | 1.00 | infobox |
| Hydroxyprogesterone caproate | Protein binding | Extensive (to albumin, not to CBGTooltip corticosteroid-binding globulin or (likely) SHBGTooltip sex hormone-binding globulin) | 1.00 | infobox |
| Hydroxyprogesterone caproate | PubChem CID | 169870 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Routes of administration | Intramuscular injection, subcutaneous autoinjection | 1.00 | infobox |
| Hydroxyprogesterone caproate | Trade names | Delalutin, Proluton, Makena, others | 1.00 | infobox |
| Hydroxyprogesterone caproate | UNII | 276F2O42F5 | 1.00 | infobox |
| Hydroxyprogesterone caproate | is a | progestin medication which was used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders | 0.90 | text |
| Hydroxyprogesterone caproate | is a | progestin | 0.90 | text |
| Hydroxyprogesterone caproate | is a | much more potent progestogen than 17α-hydroxyprogesterone | 0.90 | text |
The concept neighborhoods around Hydroxyprogesterone caproate bring nearby vocabulary together. In this analysis, examples include Hydroxyprogesterone, Injection and Intramuscular. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Hydroxyprogesterone caproate, one of the stronger structural bridges in this analysis connects Hydroxyprogesterone caproate with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Hydroxyprogesterone caproate to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Hydroxyprogesterone caproate · EN edition · Analysis: TopicsToTalkAbout